Works matching AU Ohe, Yuichiro


Results: 240
    1
    2
    3

    Evaluation of hepatic CYP3A enzyme activity using endogenous markers in lung cancer patients treated with cisplatin, dexamethasone, and aprepitant.

    Published in:
    European Journal of Clinical Pharmacology, 2022, v. 78, n. 4, p. 613, doi. 10.1007/s00228-022-03275-5
    By:
    • Hibino, Hideyuki;
    • Sakiyama, Naomi;
    • Makino, Yoshinori;
    • Makihara-Ando, Reiko;
    • Horinouchi, Hidehito;
    • Fujiwara, Yutaka;
    • Kanda, Shintaro;
    • Goto, Yasushi;
    • Yoshida, Tatsuya;
    • Okuma, Yusuke;
    • Shinno, Yuki;
    • Murakami, Shuji;
    • Hashimoto, Hironobu;
    • Akiyoshi, Takeshi;
    • Imaoka, Ayuko;
    • Ohe, Yuichiro;
    • Yamaguchi, Masakazu;
    • Ohtani, Hisakazu
    Publication type:
    Article
    4
    5
    6
    7
    8

    Activity and Immune Correlates of Programmed Death-1 Blockade Therapy in Patients With Advanced Large Cell Neuroendocrine Carcinoma.

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 4, p. 282, doi. 10.1016/j.cllc.2021.02.003
    By:
    • Shirasawa, Masayuki;
    • Yoshida, Tatsuya;
    • Takayanagi, Daisuke;
    • Shiraishi, Kouya;
    • Yagishita, Shigehiro;
    • Sekine, Katsutoshi;
    • Kanda, Shintaro;
    • Matsumoto, Yuji;
    • Masuda, Ken;
    • Shinno, Yuki;
    • Okuma, Yusuke;
    • Goto, Yasushi;
    • Horinouchi, Hidehito;
    • Hamada, Akinobu;
    • Kohno, Takashi;
    • Yamamoto, Noboru;
    • Watanabe, Shun-ichi;
    • Ohe, Yuichiro;
    • Motoi, Noriko
    Publication type:
    Article
    9
    10
    11

    Comparison of Radiotherapy and Chemoradiotherapy for Locoregional Recurrence of Non-small-cell Lung Cancer Developing After Surgery.

    Published in:
    2017
    By:
    • Shinji Nakamichi;
    • Hidehito Horinouchi;
    • Tetsuhiko Asao;
    • Yasushi Goto;
    • Shintaro Kanda;
    • Yutaka Fujiwara;
    • Hiroshi Nokihara;
    • Noboru Yamamoto;
    • Yoshinori Ito;
    • Shun-ichi Watanabe;
    • Yuichiro Ohe;
    • Nakamichi, Shinji;
    • Horinouchi, Hidehito;
    • Asao, Tetsuhiko;
    • Goto, Yasushi;
    • Kanda, Shintaro;
    • Fujiwara, Yutaka;
    • Nokihara, Hiroshi;
    • Yamamoto, Noboru;
    • Ito, Yoshinori
    Publication type:
    journal article
    12

    Sequential Use of Anaplastic Lymphoma Kinase Inhibitors in Japanese Patients With ALK-Rearranged Non-Small-Cell Lung Cancer: A Retrospective Analysis.

    Published in:
    2017
    By:
    • Tetsuhiko Asao;
    • Yutaka Fujiwara;
    • Itahashi, Kota;
    • Shinsuke Kitahara;
    • Yasushi Goto;
    • Hidehito Horinouchi;
    • Shintaro Kanda;
    • Hiroshi Nokihara;
    • Noboru Yamamoto;
    • Kazuhisa Takahashi;
    • Yuichiro Ohe;
    • Asao, Tetsuhiko;
    • Fujiwara, Yutaka;
    • Kitahara, Shinsuke;
    • Goto, Yasushi;
    • Horinouchi, Hidehito;
    • Kanda, Shintaro;
    • Nokihara, Hiroshi;
    • Yamamoto, Noboru;
    • Takahashi, Kazuhisa
    Publication type:
    journal article
    13

    Comparison of Amrubicin and Weekly Cisplatin/Etoposide/Irinotecan in Patients With Relapsed Small-cell Lung Cancer.

    Published in:
    2017
    By:
    • Hitomi Sumiyoshi Okuma;
    • Hidehito Horinouchi;
    • Shinsuke Kitahara;
    • Tetsuhiko Asao;
    • Kuniko Sunami;
    • Yasushi Goto;
    • Shintaro Kanda;
    • Yutaka Fujiwara;
    • Hiroshi Nokihara;
    • Noboru Yamamoto;
    • Yuichiro Ohe;
    • Okuma, Hitomi Sumiyoshi;
    • Horinouchi, Hidehito;
    • Kitahara, Shinsuke;
    • Asao, Tetsuhiko;
    • Sunami, Kuniko;
    • Goto, Yasushi;
    • Kanda, Shintaro;
    • Fujiwara, Yutaka;
    • Nokihara, Hiroshi
    Publication type:
    journal article
    14
    15
    16
    17

    Neoadjuvant chemotherapy promotes the expression of HER3 in patients with ovarian cancer.

    Published in:
    Oncology Letters, 2020, v. 20, n. 6, p. N.PAG, doi. 10.3892/ol.2020.12200
    By:
    • Mizuno, Takaaki;
    • Kojima, Yuki;
    • Yonemori, Kan;
    • Yoshida, Hiroshi;
    • Sugiura, Yukiko;
    • Ohtake, Yohei;
    • Okuma, Hitomi S.;
    • Nishikawa, Tadaaki;
    • Tanioka, Maki;
    • Sudo, Kazuki;
    • Shimomura, Akihiko;
    • Noguchi, Emi;
    • Kato, Tomoyasu;
    • Shimoi, Tatsunori;
    • Uno, Masaya;
    • Ishikawa, Mitsuya;
    • Fujiwara, Yasuhiro;
    • Ohe, Yuichiro;
    • Tamura, Kenji
    Publication type:
    Article
    18

    HER3 protein expression as a risk factor for post-operative recurrence in patients with early-stage adenocarcinoma and adenosquamous carcinoma of the cervix.

    Published in:
    Oncology Letters, 2020, v. 20, n. 4, p. N.PAG
    By:
    • Mizuno, Takaaki;
    • Kojima, Yuki;
    • Yonemori, Kan;
    • Yoshida, Hiroshi;
    • Sugiura, Yukiko;
    • Ohtake, Yohei;
    • Okuma, Hitomi S.;
    • Nishikawa, Tadaaki;
    • Tanioka, Maki;
    • Sudo, Kazuki;
    • Shimomura, Akihiko;
    • Noguchi, Emi;
    • Kato, Tomoyasu;
    • Shimoi, Tatsunori;
    • Uno, Masaya;
    • Ishikawa, Mitsuya;
    • Fujiwara, Yasuhiro;
    • Ohe, Yuichiro;
    • Tamura, Kenji
    Publication type:
    Article
    19
    20
    21
    22
    23

    Protocol summary of a randomized phase III study: comparing systemic therapy with and without debulking surgery (primary tumour resection) for clinical stage IVA (cT1-2bN0-1M1a) non-small cell lung cancer with radiologically undetermined pleural dissemination JCOG2103 (DEBULK-LUNG)

    Published in:
    Japanese Journal of Clinical Oncology, 2025, v. 55, n. 2, p. 176, doi. 10.1093/jjco/hyae143
    By:
    • Sekino, Yuta;
    • Hishida, Tomoyuki;
    • Yoshioka, Hiroshige;
    • Wakabayashi, Masashi;
    • Mitome, Noriko;
    • Shiono, Satoshi;
    • Kenmotsu, Hirotsugu;
    • Nosaki, Kaname;
    • Aokage, Keiju;
    • Horinouchi, Hidehito;
    • Fukuda, Haruhiko;
    • Ohe, Yuichiro;
    • Watanabe, Shun-ichi;
    • (JCOG), the Lung Cancer Surgical Study Group (LCSSG) and the Lung Cancer Study Group (LCSG) of the Japan Clinical Oncology Group
    Publication type:
    Article
    24
    25
    26
    27
    28
    29

    Medical management of older patients with lung cancer.

    Published in:
    Japanese Journal of Clinical Oncology, 2022, v. 52, n. 10, p. 1082, doi. 10.1093/jjco/hyac135
    By:
    • Zenke, Yoshitaka;
    • Hakozaki, Taiki;
    • Nakahara, Yoshiro;
    • Horinouchi, Hidehito;
    • Ohe, Yuichiro;
    • (JCOG), the Lung Cancer Study Group of the Japan Clinical Oncology Group
    Publication type:
    Article
    30
    31

    Study protocol for JCOG1807C (DEEP OCEAN): a interventional prospective trial to evaluate the efficacy and safety of durvalumab before and after operation or durvalumab as maintenance therapy after chemoradiotherapy against superior sulcus non-small cell lung cancer

    Published in:
    Japanese Journal of Clinical Oncology, 2022, v. 52, n. 4, p. 383, doi. 10.1093/jjco/hyab208
    By:
    • Aokage, Keiju;
    • Tsuboi, Masahiro;
    • Zenke, Yoshitaka;
    • Horinouchi, Hidehito;
    • Nakamura, Naoki;
    • Ishikura, Satoshi;
    • Nishikawa, Hiroyoshi;
    • Kumagai, Shogo;
    • Koyama, Shohei;
    • Kanato, Keisuke;
    • Kataoka, Tomoko;
    • Wakabayashi, Masashi;
    • Fukutani, Miki;
    • Fukuda, Haruhiko;
    • Ohe, Yuichiro;
    • Watanabe, Shun-ichi;
    • Group, the Lung Cancer Surgical Study Group of the Japan Clinical Oncology
    Publication type:
    Article
    32

    Early specialized palliative care for patients with metastatic lung cancer receiving chemotherapy: a feasibility study of a nurse-led screening-triggered programme.

    Published in:
    Japanese Journal of Clinical Oncology, 2022, v. 52, n. 4, p. 375, doi. 10.1093/jjco/hyab204
    By:
    • Matsumoto, Yoshihisa;
    • Umemura, Shigeki;
    • Okizaki, Ayumi;
    • Fujisawa, Daisuke;
    • Kobayashi, Naoko;
    • Tanaka, Yuko;
    • Sasaki, Chiyuki;
    • Shimizu, Ken;
    • Ogawa, Asao;
    • Kinoshita, Hiroya;
    • Uchitomi, Yosuke;
    • Yoshiuchi, Kazuhiro;
    • Matsuyama, Yutaka;
    • Morita, Tatsuya;
    • Goto, Koichi;
    • Ohe, Yuichiro
    Publication type:
    Article
    33

    Performance of Japanese patients in registrational studies.

    Published in:
    Japanese Journal of Clinical Oncology, 2022, v. 52, n. 1, p. 53, doi. 10.1093/jjco/hyab171
    By:
    • Goto, Yasushi;
    • Arakawa, Sayaka;
    • Shirasawa, Masayuki;
    • Higashiyama, Ryoko;
    • Baba, Keisuke;
    • Masuda, Ken;
    • Shinno, Yuki;
    • Matsumoto, Yuji;
    • Okuma, Yusuke;
    • Yoshida, Tatsuya;
    • Horinouchi, Hidehito;
    • Yamamoto, Noboru;
    • Ohe, Yuichiro
    Publication type:
    Article
    34

    Study protocol for NCCH1908 (UPFRONT-trial): a prospective clinical trial to evaluate the feasibility and utility of comprehensive genomic profiling prior to the initial systemic treatment in advanced solid tumour patients.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 12, p. 1757, doi. 10.1093/jjco/hyab159
    By:
    • Mizuno, Takaaki;
    • Yoshida, Tatsuya;
    • Sunami, Kuniko;
    • Koyama, Takafumi;
    • Okita, Natsuko;
    • Kubo, Takashi;
    • Sudo, Kazuki;
    • Shimoi, Tatsunori;
    • Ueno, Hideki;
    • Saito, Eiko;
    • Katanoda, Kota;
    • Shibata, Taro;
    • Yonemori, Kan;
    • Okusaka, Takuji;
    • Boku, Narikazu;
    • Ohe, Yuichiro;
    • Hiroshima, Yukihiko;
    • Ueno, Makoto;
    • Kuboki, Yasutoshi;
    • Doi, Toshihiko
    Publication type:
    Article
    35

    Corrigendum to: Feasibility of next-generation sequencing (Oncomine™ DX Target Test) for the screening of oncogenic mutations in advanced non-small-cell lung cancer patients.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 7, p. 1183, doi. 10.1093/jjco/hyab092
    By:
    • Takeyasu, Yuki;
    • Yoshida, Tatsuya;
    • Motoi, Noriko;
    • Teishikata, Takashi;
    • Tanaka, Midori;
    • Matsumoto, Yuji;
    • Shinno, Yuki;
    • Okuma, Yusuke;
    • Goto, Yasushi;
    • Horinouchi, Hidehito;
    • Kakishima, Hiroki;
    • Tsuchida, Takaaki;
    • Yamamoto, Noboru;
    • Ohe, Yuichiro;
    • Yatabe, Yasushi
    Publication type:
    Article
    36

    Feasibility of next-generation sequencing (Oncomine™ DX Target Test) for the screening of oncogenic mutations in advanced non-small-cell lung cancer patients.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 7, p. 1114, doi. 10.1093/jjco/hyab059
    By:
    • Takeyasu, Yuki;
    • Yoshida, Tatsuya;
    • Motoi, Noriko;
    • Teishikata, Takashi;
    • Tanaka, Midori;
    • Matsumoto, Yuji;
    • Shinno, Yuki;
    • Okuma, Yusuke;
    • Goto, Yasushi;
    • Horinouchi, Hidehito;
    • Kakishima, Hiroki;
    • Tsuchida, Takaaki;
    • Yamamoto, Noboru;
    • Ohe, Yuichiro;
    • Yatabe, Yasushi
    Publication type:
    Article
    37

    A multi-institutional randomized phase III study comparing weekly carboplatin plus nab-paclitaxel and daily low-dose carboplatin as regimens for concurrent chemoradiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG1914

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 5, p. 836, doi. 10.1093/jjco/hyab025
    By:
    • Shimoyama, Ryo;
    • Omori, Shota;
    • Nomura, Shogo;
    • Kenmotsu, Hirotsugu;
    • Takahashi, Toshiaki;
    • Harada, Hideyuki;
    • Ishikura, Satoshi;
    • Mizutani, Tomonori;
    • Ando, Masahiko;
    • Kataoka, Tomoko;
    • Fukuda, Haruhiko;
    • Ohe, Yuichiro;
    • Group, the Lung Cancer Study Group in the Japan Clinical Oncology
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50